DuoGenic StemCells Corporation(TW:7607)
NT$13.20+0.90 (+7.32%)
TW:7607
DuoGenic StemCells Corporation financials statements
NT$13.20
At close:+0.90 (+7.32%)
DuoGenic StemCells Corporation (7607) Ratios
DuoGenic StemCells Corporation Ratios
TW:7607's free cash flow for Q2 2026 was NT$-33.91M. For the 2026 fiscal year, TW:7607's free cash flow was decreased by NT$-1.80M and operating cash flow was NT$-32.11M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.24 | 0.96 | 6.44 | 7.80 | 15.19 |
| Quick Ratio | 2.15 | 0.85 | 5.30 | 6.99 | 14.48 |
| Cash Ratio | 1.88 | 0.64 | 4.47 | 6.13 | 13.72 |
| Solvency Ratio | -0.74 | -1.27 | -2.45 | -3.33 | -4.35 |
| Operating Cash Flow Ratio | -0.70 | -1.21 | -4.22 | -4.79 | -5.35 |
| Short-Term Operating Cash Flow Coverage | -0.92 | -1.58 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | NT$ 31.83M | NT$ -5.21M | NT$ 51.11M | NT$ 45.89M | NT$ 52.48M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.28 | 0.60 | 0.08 | 0.03 | 0.02 |
| Debt-to-Equity Ratio | 0.44 | 2.13 | 0.09 | 0.04 | 0.02 |
| Debt-to-Capital Ratio | 0.30 | 0.68 | 0.08 | 0.04 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.54 | 3.54 | 1.20 | 1.12 | 1.06 |
| Debt Service Coverage Ratio | -0.94 | -1.76 | -237.89 | -421.29 | -409.98 |
| Interest Coverage Ratio | -28.63 | -109.54 | -280.53 | -491.47 | -492.38 |
| Debt to Market Cap | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.75 | 1.19 | 0.24 | 0.10 | 0.06 |
| Net Debt to EBITDA | 1.40 | -0.20 | 1.03 | 1.41 | 2.48 |
| Profitability Margins | |||||
| Gross Profit Margin | 76.33% | 34.04% | 35.85% | -6.59% | -216.67% |
| EBIT Margin | -123.36% | -506.64% | -328.59% | -490.61% | -992.51% |
| EBITDA Margin | -94.84% | -446.19% | -277.28% | -412.88% | -876.53% |
| Operating Profit Margin | -124.65% | -506.23% | -328.42% | -487.03% | -1007.49% |
| Pretax Profit Margin | -127.71% | -511.26% | -329.77% | -491.61% | -994.56% |
| Net Profit Margin | -127.48% | -510.94% | -330.99% | -496.21% | -956.90% |
| Continuous Operations Profit Margin | -127.48% | -510.94% | -330.99% | -496.21% | -956.90% |
| Net Income Per EBT | 99.82% | 99.94% | 100.37% | 100.94% | 96.21% |
| EBT Per EBIT | 102.46% | 100.99% | 100.41% | 100.94% | 98.72% |
| Return on Assets (ROA) | -33.59% | -103.23% | -48.12% | -41.40% | -29.66% |
| Return on Equity (ROE) | -51.74% | -365.62% | -57.68% | -46.25% | -31.55% |
| Return on Capital Employed (ROCE) | -49.53% | -295.07% | -53.66% | -44.41% | -32.89% |
| Return on Invested Capital (ROIC) | -35.17% | -115.81% | -52.44% | -43.77% | -31.26% |
| Return on Tangible Assets | -33.79% | -104.79% | -49.02% | -42.73% | -30.11% |
| Earnings Yield | -4.64% | -8.72% | -4.08% | -1.88% | -1.36% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.60 | 3.47 | 3.93 | 2.60 | 14.18 |
| Payables Turnover | 22.06 | 87.35 | 85.96 | 34.50 | 78.22 |
| Inventory Turnover | 2.05 | 1.80 | 0.74 | 1.28 | 2.73 |
| Fixed Asset Turnover | 1.72 | 0.63 | 0.58 | 0.30 | 0.15 |
| Asset Turnover | 0.26 | 0.20 | 0.15 | 0.08 | 0.03 |
| Working Capital Turnover Ratio | 1.31 | 0.44 | 0.26 | 0.14 | 0.00 |
| Cash Conversion Cycle | 226.92 | 303.41 | 580.86 | 415.19 | 154.85 |
| Days of Sales Outstanding | 65.21 | 105.27 | 92.89 | 140.27 | 25.74 |
| Days of Inventory Outstanding | 178.25 | 202.31 | 492.22 | 285.50 | 133.78 |
| Days of Payables Outstanding | 16.54 | 4.18 | 4.25 | 10.58 | 4.67 |
| Operating Cycle | 243.46 | 307.59 | 585.10 | 425.77 | 159.52 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.60 | -1.55 | -1.45 | -1.16 | -0.78 |
| Free Cash Flow Per Share | -0.61 | -1.59 | -1.48 | -1.58 | -1.13 |
| Dividend Paid and CapEx Coverage Ratio | -71.88 | -39.16 | -43.62 | -2.78 | -2.22 |
| Capital Expenditure Coverage Ratio | -71.88 | -39.16 | -43.62 | -2.78 | -2.22 |
| Operating Cash Flow Coverage Ratio | -0.83 | -1.32 | -6.09 | -12.21 | -12.90 |
| Operating Cash Flow to Sales Ratio | -0.89 | -3.93 | -3.19 | -4.87 | -8.72 |
| Free Cash Flow Yield | -3.29% | -6.87% | -4.03% | -2.51% | -1.80% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -21.45 | -11.49 | -24.50 | -53.39 | -73.26 |
| Price-to-Sales (P/S) Ratio | 27.50 | 58.56 | 81.09 | 264.38 | 702.30 |
| Price-to-Book (P/B) Ratio | 11.16 | 41.91 | 14.13 | 24.64 | 23.15 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -30.39 | -14.55 | -24.82 | -39.90 | -55.54 |
| Price-to-Operating Cash Flow Ratio | -30.81 | -14.92 | -25.38 | -54.28 | -80.51 |
| Price-to-Earnings Growth (PEG) Ratio | 0.37 | -0.34 | -0.90 | -1.43 | 0.00 |
| Enterprise Value Multiple | -27.60 | -13.32 | -28.21 | -62.62 | -77.65 |
| Enterprise Value | 541.63M | 716.51M | 1.07B | 1.77B | 1.56B |
| EV to EBITDA | -27.60 | -13.32 | -28.21 | -62.62 | -77.65 |
| EV to Sales | 26.17 | 59.45 | 78.23 | 258.54 | 680.59 |
| EV to Free Cash Flow | -28.92 | -14.77 | -23.94 | -39.02 | -53.82 |
| EV to Operating Cash Flow | -29.32 | -15.15 | -24.49 | -53.08 | -78.02 |
| Tangible Book Value Per Share | 1.64 | 0.52 | 2.54 | 2.47 | 2.68 |
| Shareholders’ Equity Per Share | 1.65 | 0.55 | 2.60 | 2.56 | 2.72 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | -0.00 | -0.01 | 0.04 |
| Revenue Per Share | 0.67 | 0.39 | 0.45 | 0.24 | 0.09 |
| Net Income Per Share | -0.86 | -2.02 | -1.50 | -1.18 | -0.86 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.01 | 0.96 |
| Interest Burden | 1.04 | 1.01 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.74 | 2.01 | 1.05 | 2.00 | 4.48 |
| SG&A to Revenue | 1.27 | 3.39 | 2.60 | 3.22 | 4.16 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.70 | 0.77 | 0.97 | 0.98 | 0.91 |
Currency in TWD
